« Back
Home /
Oroxin A

Oroxin A

Item no.	TMO-TWS0787-100mg
Manufacturer	TargetMol
CASRN	31567-75-6
Amount	100mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	98.59%
Citations	Sun W, et al. Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice. Phytomedicine. 2018 Jan 1;38:24-34.
Smiles	OC[C@H]1O[C@@H](Oc2cc3oc(cc(=O)c3c(O)c2O)-c2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	31567-75-6, Glucokinase; PPAR, Baicalin-7-glucoside
Available
Short Description	Oroxin A is a partial PPARγ agonist that can activate PPARγ transcriptional activation in vitro and in vivo. Oroxin A also exhibited inhibitory activity against α-glucosidase and antioxidant capacity.
Shipping	cool pack
Storage	-20°
Target names or alias	Baicalin-7-glucoside
Molecular Weight	432, 38
Pathway	Metabolism\|\|\|DNA Damage/DNA Repair
Target	Glucosidase\|\|\|PPAR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 4 days

Compare

Add to wishlist

Recommend by mail